{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:50:39Z","timestamp":1780080639561,"version":"3.54.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005013","name":"Iranian Academic Center for Education, Culture and Research (ACECR)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005013","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ctim.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T21:16:30Z","timestamp":1375737390000},"page":"441-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: A randomized placebo. Controlled clinical trial"],"prefix":"10.1016","volume":"21","author":[{"given":"S.","family":"Kianbakht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Hashem","family":"Dabaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2013.07.004_bib0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1463-1326.2010.01342.x","article-title":"Therapies for diabetic dyslipidemia","volume":"13","author":"Bell","year":"2010","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.ctim.2013.07.004_bib0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/00003495-200767070-00005","article-title":"Approaches to prevention of cardiovascular complications and events in diabetes mellitus","volume":"67","author":"Coccheri","year":"2007","journal-title":"Drugs"},{"issue":"Suppl.","key":"10.1016\/j.ctim.2013.07.004_bib0015","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.4065\/mcp.2010.0471","article-title":"Defining and achieving treatment success in patients with type 2 diabetes mellitus","volume":"85","author":"Stolar","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.ctim.2013.07.004_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1742-1241.2008.01980.x","article-title":"Treating type 2 diabetes: how safe are current therapeutic agents?","volume":"63","author":"Philippe","year":"2009","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.ctim.2013.07.004_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14728222.11.2.181","article-title":"MTP inhibition as a treatment for dyslipidemias: time to deliver or empty promises?","volume":"11","author":"Burnett","year":"2007","journal-title":"Expert Opinion in Therapeutic Targets"},{"key":"10.1016\/j.ctim.2013.07.004_bib0030","doi-asserted-by":"crossref","first-page":"262S","DOI":"10.3945\/ajcn.2009.28449D","article-title":"Peroxisome proliferator-activated receptor translational research and clinical experience","volume":"91","author":"Cheatham","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.ctim.2013.07.004_bib0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/14728222.2010.512917","article-title":"PPARs as therapeutic targets in cardiovascular disease","volume":"14","author":"van Bilsen","year":"2010","journal-title":"Expert Opinion in Therapeutic Targets"},{"key":"10.1016\/j.ctim.2013.07.004_bib0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1874467211205020272","article-title":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) agonists on glycemic control, lipid profile and cardiovascular risk","volume":"5","author":"Derosa","year":"2012","journal-title":"Current Molecular Pharmacology"},{"key":"10.1016\/j.ctim.2013.07.004_bib0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1742-7843.2005.pto960102.x","article-title":"Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome","volume":"96","author":"Huang","year":"2005","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"key":"10.1016\/j.ctim.2013.07.004_bib0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/138955710791331007","article-title":"Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycemic potential in the treatment of diabetes: an update","volume":"10","author":"Tundis","year":"2010","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"10.1016\/j.ctim.2013.07.004_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1520-037X.2000.80355.x","article-title":"Herbs and dietary supplements in the prevention and treatment of cardiovascular disease","volume":"3","author":"Fugh-Berman","year":"2000","journal-title":"Prevntive Cardiology"},{"issue":"Suppl. 4","key":"10.1016\/j.ctim.2013.07.004_bib0060","first-page":"S4","article-title":"Health benefits of herbs and spices: the past, the present, the future","volume":"185","author":"Tapsell","year":"2006","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.ctim.2013.07.004_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000102594","article-title":"PPAR ligands: are they potential agents for cardiovascular disorders?","volume":"80","author":"Balakumar","year":"2007","journal-title":"Pharmacology"},{"key":"10.1016\/j.ctim.2013.07.004_bib0070","first-page":"59","volume":"Vol. 4","author":"Zargari","year":"1997"},{"key":"10.1016\/j.ctim.2013.07.004_bib0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-2006-946680","article-title":"Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma","volume":"72","author":"Rau","year":"2006","journal-title":"Planta Medica"},{"key":"10.1016\/j.ctim.2013.07.004_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jep.2010.07.054","article-title":"Activation of the nuclear receptor PPAR\u03b3 by metabolites isolated from sage (Salvia officinalis L.)","volume":"132","author":"Christensen","year":"2010","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.ctim.2013.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.bmcl.2004.01.091","article-title":"Carnosic acid, a new class of lipid absorption inhibitor from sage","volume":"14","author":"Ninomiya","year":"2004","journal-title":"Bioorganic and Medicinal Chemisrty Letters"},{"key":"10.1016\/j.ctim.2013.07.004_bib0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/jmf.2008.0007","article-title":"Antioxidant and inhibitory effects of aqueous extracts of Salvia officinalis leaves on pro-oxidant-induced lipid peroxidation in brain and liver in vitro","volume":"12","author":"Oboh","year":"2009","journal-title":"Journal of Medicinal Food"},{"key":"10.1016\/j.ctim.2013.07.004_bib0095","first-page":"290","article-title":"Effects of Salvia officinalis L. extract on experimental acute inflammation","volume":"111","author":"Oniga","year":"2007","journal-title":"Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi"},{"key":"10.1016\/j.ctim.2013.07.004_bib0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jep.2005.03.008","article-title":"Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozocin-induced diabetic rats","volume":"100","author":"Eidi","year":"2005","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.ctim.2013.07.004_bib0105","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1079\/BJN20061832","article-title":"Metformine-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention?","volume":"96","author":"Lima","year":"2006","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.ctim.2013.07.004_bib0110","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.3390\/ijms10093937","article-title":"Sage tea drinking improves lipid profile and antioxidant defenses in humans","volume":"10","author":"Sa","year":"2009","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.ctim.2013.07.004_bib0115","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/ptr.3506","article-title":"Anti-hyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial","volume":"25","author":"Kianbakht","year":"2011","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.ctim.2013.07.004_bib0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1745-4522.2007.00077.x","article-title":"Phenolic compounds of Origanum sipyleum L. extract, and its antioxidant and antibacterial activities","volume":"14","author":"Ozkan","year":"2007","journal-title":"Journal of Food Lipids"},{"key":"10.1016\/j.ctim.2013.07.004_bib0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.foodchem.2007.01.031","article-title":"Antioxidants from a Chinese medicinal herb \u2013 Lithospermum erythrorhizon","volume":"106","author":"Han","year":"2008","journal-title":"Food Chemistry"},{"key":"10.1016\/j.ctim.2013.07.004_bib0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.foodchem.2007.07.006","article-title":"Relative antioxidant and cytoprotective activities of common herbs","volume":"106","author":"Yoo","year":"2008","journal-title":"Food Chemistry"},{"key":"10.1016\/j.ctim.2013.07.004_bib0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0308-8146(02)00423-5","article-title":"Antioxidant capacity of phenolic phytochemicals from various cultivars of plums","volume":"81","author":"Kim","year":"2003","journal-title":"Food Chemistry"},{"key":"10.1016\/j.ctim.2013.07.004_bib0140","series-title":"The United States Pharmacopoeial Convention. USP","first-page":"2094","year":"2004"},{"key":"10.1016\/j.ctim.2013.07.004_bib0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.4113","article-title":"Oxidative stress and myocardial injury in the diabetic heart","volume":"229","author":"Ansley","year":"2013","journal-title":"Journal of Pathology"},{"key":"10.1016\/j.ctim.2013.07.004_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pcad.2004.04.007","article-title":"Comparative effects of lipid-lowering therapies","volume":"47","author":"Davidson","year":"2004","journal-title":"Progress in Cardiovascular Diseases"},{"key":"10.1016\/j.ctim.2013.07.004_bib0155","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1592\/phco.24.17.1692.52340","article-title":"Pharmacologic treatment of type 2 diabetic dyslipidemia","volume":"24","author":"Moon","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ctim.2013.07.004_bib0160","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1517\/14656566.4.11.1901","article-title":"Pharmacotherapy for dyslipidemia \u2013 current therapies and future agents","volume":"4","author":"Bays","year":"2003","journal-title":"Expert Opinion in Pharmacotherapy"},{"key":"10.1016\/j.ctim.2013.07.004_bib0165","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/j.1755-5922.2011.00267.x","article-title":"Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge","volume":"30","author":"Fung","year":"2012","journal-title":"Cardiovascular Therapy"},{"key":"10.1016\/j.ctim.2013.07.004_bib0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.18388\/abp.2010_2443","article-title":"Core structure of flavonoids precursor as an anti-hyperglycemic and anti-hyperlipidemic agent: an in vivo study in rats","volume":"57","author":"Najafian","year":"2010","journal-title":"Acta Biochimica Polonica"},{"key":"10.1016\/j.ctim.2013.07.004_bib0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1259\/bjr\/30930369","article-title":"Liposoluble antioxidants provide an effective radioprotective barrier","volume":"82","author":"Alcaraz","year":"2009","journal-title":"British Journal Radiology"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229913001180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229913001180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:01:52Z","timestamp":1760806912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229913001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0965229913001180"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2013.07.004","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: A randomized placebo. Controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}